Form 4 for WST West Pharmaceutical Services
Accepted 2023-08-15 00:00:00 ET · period of report 2023-08-11 · accession 0001562180-23-006338 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-08-15 | 2023-08-11 | WST | Lai Quintin J | VP Strat, Investor Relations | S - Sale+OE | $395.12 | -21.1K | 18.3K | -54% | -$8.34M |
| DM | 2023-08-15 | 2023-08-11 | WST | Lai Quintin J | VP Strat, Investor Relations | M - OptEx | $125.40 | +21.1K | 39.4K | +115% | +$2.65M |
| DM | 2023-08-15 | 2023-08-11 | WST | Lai Quintin J | VP Strat, Investor Relations | M - OptEx | $0.00 | -21.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-11 | S | D | 10,725 | $394.62 | 28,682.93 | D | — | — | (F1) The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $393.97 to $394.96, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. |
| 2 | Common | Common Stock | 2023-08-11 | M | A | 1,388 | $274.29 | 38,954.93 | D | — | — | |
| 3 | Common | Common Stock | 2023-08-11 | M | A | 3,348 | $173.22 | 37,566.93 | D | — | — | |
| 4 | Common | Common Stock | 2023-08-11 | M | A | 7,140 | $102.51 | 34,218.93 | D | — | — | |
| 5 | Common | Common Stock | 2023-08-11 | M | A | 8,772 | $89.64 | 27,078.93 | D | — | — | |
| 6 | Common | Common Stock | 2023-08-11 | M | A | 453 | $369.13 | 39,407.93 | D | — | — | |
| 7 | Common | Common Stock | 2023-08-11 | S | D | 8,635 | $395.54 | 20,047.93 | D | — | — | (F2) The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $394.97 to $395.93, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. |
| 8 | Common | Common Stock | 2023-08-11 | S | D | 1,741 | $396.12 | 18,306.93 | D | — | — | (F3) The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $395.97 to $396.45, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. |
| 9 | Derivative | Stock Options (Right to buy) | 2023-08-11 | M | D | 7,140 | $0.00 | 0 | D | $102.51 · 2020-02-19 to 2029-02-19 | 7,140 Common Stock | (F4) This option is fully vested. |
| 10 | Derivative | Stock Options (Right to buy) | 2023-08-11 | M | D | 453 | $0.00 | 1,359 | D | $369.13 · 2023-02-22 to 2032-02-22 | 453 Common Stock | (F7) This award vests in four equal annual installments beginning on February 22, 2023. |
| 11 | Derivative | Stock Options (Right to buy) | 2023-08-11 | M | D | 1,388 | $0.00 | 1,388 | D | $274.29 · 2021-02-23 to 2031-02-23 | 1,388 Common Stock | (F6) This award vests in 4 equal annual installments beginning on 2/23/2022. |
| 12 | Derivative | Stock Options (Right to Buy) | 2023-08-11 | M | D | 3,348 | $0.00 | 1,116 | D | $173.22 · 2021-02-18 to 2030-02-18 | 3,348 Common Stock | (F5) This award vests in four equal annual installments beginning on February 18, 2021. |
| 13 | Derivative | Stock Option (Right to Buy) | 2023-08-11 | M | D | 8,772 | $0.00 | 0 | D | $89.64 · 2019-02-20 to 2028-02-20 | 8,772 Common Stock | (F4) This option is fully vested. |